We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Work and Opportunities for Women (WOW) programme is the flagship women’s economic empowerment programme funded by the UK Foreign, Commonwealth and Development Office (FCDO).
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 24 January 2025, approved garadacimab (brand name Andembry) for patients aged 12 years and older with hereditary angioedema (HAE) to prevent angioedema attacks.
VMD response to concerns raised following media reports of serious adverse events in dogs administered Librela.
ELLA is the Evidence and Lessons from Latin America programme
How ACE provided the consultants with a platform for growth, the ability to showcase quality work and access to new customers they wouldn’t otherwise have met.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).